EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Más allá de la anestesia: Rol emergente de la ketamina en el dolor crónico - Una revisión narrativa

Arturo Oscar Alcántara Chagua

ACTAS PERUANAS DE ANESTESIOLOGIA · 08.10.2025 · 23 (1) · 22-31

DOI: 10.65016/5jw6rf32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACTAS PERUANAS DE ANESTESIOLOGIA, online erschienen am 08.10.2025. Verfasst von Arturo Oscar Alcántara Chagua. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction:Chronic non-cancer pain (CNCP) is a public health problem due to its high prevalence, functional impact, and limited response to conventional therapies. Ketamine, a non-competitive NMDA receptor antagonist, has emerged as an alternative in refractory cases, particularly in complex regional pain syndrome (CRPS).MethodsA narrative review of the literature published between January 2010 and December 2023 was conducted using PubMed/MEDLINE, Cochrane Library, SciELO, and major clinical guidelines. Included studies comprised clinical trials, systematic reviews, and meta-analyses on ketamine use in adults with CNCP. Studies on acute pain, cancer, pediatrics, and recreational ketamine use were excluded. Selection was performed independently by the author, acknowledging the limitation of single-reviewer bias. No formal GRADE assessment was applied, but the level of evidence reported by each study was considered.Results:Twenty-six references were analyzed. Intravenous ketamine demonstrated consistent short-term analgesic efficacy in CRPS, while evidence in fibromyalgia and neuropathic pain was heterogeneous and of low certainty. The most common adverse events were dissociation, nausea, headache, and hypertension, generally transient. Oral and intranasal routes showed limited evidence. Foundational CRPS trials (2008--2009) were included as historical references.Conclusions:Intravenous ketamine is a therapeutic option for refractory CNCP under strict clinical supervision. Its use should be time-limited and avoided in patients with psychiatric risk factors. Further multicenter, high-quality trials are urgently needed to define optimal protocols, long-term safety, and the patient subgroups most likely to benefit.

Zitieren

APA

Chagua, A. O. A. (2025). Más allá de la anestesia: Rol emergente de la ketamina en el dolor crónico - Una revisión narrativa. ACTAS PERUANAS DE ANESTESIOLOGIA, 23(1), 22-31. https://doi.org/10.65016/5jw6rf32

Vancouver

Chagua AOA. Más allá de la anestesia: Rol emergente de la ketamina en el dolor crónico - Una revisión narrativa. ACTAS PERUANAS DE ANESTESIOLOGIA. 2025;23(1):22-31. doi:10.65016/5jw6rf32

BibTeX
@article{Chagua2025,
  author = {Chagua, Arturo Oscar Alcántara},
  title = {Más allá de la anestesia: Rol emergente de la ketamina en el dolor crónico - Una revisión narrativa},
  journal = {ACTAS PERUANAS DE ANESTESIOLOGIA},
  year = {2025},
  volume = {23},
  number = {1},
  pages = {22--31},
  doi = {10.65016/5jw6rf32}
}
Kostenlos starten →